Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months

Added October 10, 2019

Citation: Lassi Z.S., Imdad A., Bhutta Z.A. Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months. Cochrane Database of Systematic Reviews 2017, Issue 10. Art. No.: CD008032.

Authors identified no randomised controlled trials comparing a short course (two to three days) of intravenous antibiotics compared to a long course (five days) for severe pneumonia in children aged two months to 59 months that met the inclusion criteria.

The WHO recommends intravenous antibiotics for five days as first-line treatment for children with severe pneumonia. This review aims to evaluate the efficacy of short-course versus long-course intravenous therapy (alone or in combination with oral antibiotics) with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months.

 

الإنكار 免责声明 免責聲明 Disclaimer Clause de non-responsabilité Haftungsausschluss Disclaimer 免責事項 Aviso legal Exención de responsabilidad

Share